CVS, Upbeat Q4

CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a recent >10% stock rally. See more.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would now like to pass the conference over to your host,
Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’
CVS Health Stock Pops as Q4 Sales, Earnings Top Estimates
Shares of CVS Health (CVS) surged Wednesday morning after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results. CVS reported adjusted earnings per share (EPS) of $1.
CVS Health jumps as pharmacy and insurance units drive Q4 beat
CVS Health (CVS) stock jumps 9% after beating Q4 revenue & earnings forecasts thanks mainly to its Health Care Benefits and Pharmacy segments. Read more here.
CVS Health Is About to Report Q4 Earnings Tomorrow. Here’s What to Expect
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market opens on
CVS Showered With Upgrades, PT Hikes After Q4 Beat Powers Stock To Best Day In Over 25 Years: Retail Cheer Grows
Shares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected quarterly earnings. The stock surged nearly 15% on Wednesday, marking its best single-day gain since Oct.
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.
CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of $97.20 billion,
Leerink Partners Upgrades CVS Health (CVS)
Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform. Analyst Price Forecast Suggests 3.67% Upside As of January 28,
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00.
Modern Healthcare2d
CVS soars after Q4 profit signals improvement
Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...
CVS soars after fourth-quarter profit signals improvement
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...